Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results
Sanuwave (NASDAQ: SNWV) will host a live conference call on March 27, 2026 at 8:30 AM ET to present Q4 and full year 2025 financial results.
Rhea-AI Summary
Sanuwave (NASDAQ: SNWV) will host a live conference call on March 27, 2026 at 8:30 AM ET to present Q4 and full year 2025 financial results. Telephone and instant-access webcast details, conference and replay IDs, and investor materials will be available on the company website.
Telephone dial-in, international numbers, and replay instructions are provided; a replay will be available through April 10, 2026.
Positive
- None.
Negative
- None.
Details
News Market Reaction – SNWV
On Mar 20, the day this news came out, SNWV closed 1.56% below the previous close.
Data tracked by StockTitan Argus for the Mar 20 session.
Key Figures
- Earnings call date
- March 27, 2026
- Q4 and Full Year 2025 results conference call
- Call time
- 8:30 AM (ET)
- Scheduled start time for earnings conference call
- Toll-free dial-in
- 1-800-343-4136
- Participant dial-in number for the live call
- International dial-in
- 1-203-518-9843
- International access number for the live call
- Replay end date
- April 10, 2026
- Last day the call replay is available
- Replay toll-free
- 1-844-512-2921
- Toll-free number to access the call replay
- Replay ID
- 1161147
- Replay Access ID for the recorded call
- Conference ID
- SANUWAVE
- Conference ID used to join the live call
Previous Conferences,earnings Reports
-
Announced Nov 7, 2025 call to present Q3 2025 financial results.
-
Scheduled Aug 8, 2025 call to discuss Q2 2025 financial results.
-
Set May 9, 2025 call for Q1 2025 financial results discussion.
-
Announced Mar 21, 2025 call on Q4 and full-year 2024 results.
-
Planned Nov 8, 2024 call to present Q3 2024 financial results.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDEN PRAIRIE, Minn., March 20, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, March 27, 2026, at 8:30 AM (ET) to present its Q4 and Full Year 2025 financial results.
Telephone access to the call will be available by dialing the following numbers:
Participant Dial-in Information
Toll Free: 1-800-343-4136
Toll/International: 1-203-518-9843
Conference ID: SANUWAVE
OR click the link for instant telephone access to the event:
https://viavid.webcasts.com/starthere.jsp?ei=1753775&tp_key=6ca0a4cd2b
Materials for the conference call will be included on the Company’s website at www.sanuwave.com/investors.
A replay will be made available through Friday April 10, 2026:
Toll-Free: 1-844-512-2921 or 1-412-317-6671
Replay Access ID: 1161147
About Sanuwave
Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
Sanuwave's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations, plans for future business development activities and expectations regarding the impact of changes in tariff rates. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with regulatory oversight, the Company’s ability to manage its capital resources, competition and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.